login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ImmunoGen Inc (IMGN) Stock News
USA
- NASDAQ:IMGN -
US45253H1014
-
Common Stock
31.23
USD
0 (0%)
Last: 2/9/2024, 8:00:02 PM
31.24
USD
+0.01 (+0.03%)
After Hours:
2/9/2024, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IMGN Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: InvestorPlace
- Mentions:
NVDA
ABBV
CRM
CERE
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
2 years ago - By: Bloomberg
- Mentions:
ABBV
CERE
AbbVie Selling $15 Billion Bonds to Buy ImmunoGen, Cerevel
2 years ago - By: Bloomberg
- Mentions:
ABBV
CERE
AbbVie Eyes Selling at Least $13 Billion of Bonds to Fund M&A
2 years ago - By: Seeking Alpha
- Mentions:
ABBV
CERE
AbbVie revises Q1 earnings outlook as ImmunoGen deal closes (NYSE:ABBV)
2 years ago - By: AbbVie
- Mentions:
ABBV
AbbVie Completes Acquisition of ImmunoGen
2 years ago - By: Investor's Business Daily
- Mentions:
MDGL
ALKS
Madrigal Pharmaceuticals Stock Shows Rising Relative Strength
2 years ago - By: Investor's Business Daily
- Mentions:
SAVA
AMPH
ALKS
Cassava Sciences Stock Continues Showing Rising Relative Strength
2 years ago - By: Investor's Business Daily
- Mentions:
FOLD
NBIX
Amicus Therapeutics Stock Sees Improved Relative Strength Rating
2 years ago - By: Seeking Alpha
- Mentions:
ABBV
ImmunoGen stock spikes as HSR period for AbbVie deal expires (NASDAQ:IMGN)
2 years ago - By: InvestorPlace
- Mentions:
NTRA
ZYME
ARDX
MRK
...
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
2 years ago - By: InvestorPlace
- Mentions:
IWM
FLR
BHP
CELH
...
7 Russell 2000 Stocks to Buy for the Next Bull Run: February 2024
2 years ago - By: Seeking Alpha
- Mentions:
PFE
ABBV
JNJ
Pharma hunt antibody-drug conjugates in China (NYSE:PFE)
2 years ago - By: The Motley Fool
- Mentions:
ABBV
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
2 years ago - By: Benzinga
- Mentions:
CERE
ABBV
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
2 years ago - By: ImmunoGen, Inc.
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 years ago - By: Seeking Alpha
- Mentions:
ABBV
AMGN
CERE
AbbVie Q4 in focus as Humira patent cliff reaches one year
2 years ago - By: BusinessInsider
- Mentions:
ABBV
CERE
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
2 years ago - By: Benzinga
- Mentions:
CERE
ABBV
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
2 years ago - By: Investor's Business Daily
- Mentions:
AXSM
ALKS
AMPH
Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating
2 years ago - By: InvestorPlace
- Mentions:
ABBV
CERE
ALB
MCD
...
7 Dividend Aristocrats That Will Pay You for Years to Come
2 years ago - By: Investor's Business Daily
- Mentions:
RARE
REGN
Ultragenyx Pharm Stock Earns IBD Stock Upgrade With RS Rating Jump To 83
2 years ago - By: The Motley Fool
- Mentions:
ABBV
CERE
Is AbbVie Stock a Buy Now?
2 years ago - By: Investor's Business Daily
- Mentions:
LLY
ARWR
XBI
BMY
...
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
2 years ago - By: ImmunoGen, Inc.
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 years ago - By: InvestorPlace
- Mentions:
VRTX
CRSP
ABBV
XLV
3 Biotech Stocks Set for Breakthroughs in 2024
2 years ago - By: Seeking Alpha
- Mentions:
BMY
ABBV
PFE
CERE
...
What's in store for biotech M&A and IPOs in 2024? (NYSE:BMY)
2 years ago - By: InvestorPlace
- Mentions:
AMPH
NBIX
3 Stocks at the Forefront of Medical Innovation
2 years ago - By: Seeking Alpha
- Mentions:
UBS
BMY
KRTX
XOM
...
M&A activity expected to pick up in 2024, bankers say
Please enable JavaScript to continue using this application.
